Doctors Note Logo

Published on: 10/1/2026

Do adults need a measles booster, and which adults do

Most adults born after 1957 who received two documented doses of MMR vaccine are considered protected for life and do not need a measles booster, but several groups may need an additional dose, including healthcare workers, international travelers, college students, people in outbreak areas, and anyone vaccinated between 1963 and 1967 with the inactivated (killed) measles vaccine. Adults born before 1957 are generally presumed immune from childhood infection, while those with unclear vaccination records can either get one MMR dose or request a blood test (titer) to confirm immunity. There are important exceptions, including pregnancy and weakened immune systems, so see below to understand which situation applies to you. If you are unsure whether your symptoms point to measles or something else, such as a rash with fever, cough, or red watery eyes, a free, instant symptom check can help you organize what you are experiencing in just a few minutes. Taking that step now gives you clearer language to bring to a clinician, helps you understand how urgent your situation may be, and points you toward the right next step before a contagious illness spreads to others.

Last reviewed for medical accuracy: 10/01/2025

answer background

Explanation

Do Adults Need a Measles Booster?

Measles is a highly contagious viral illness that, in adults, can lead to serious complications such as pneumonia, encephalitis (brain swelling), and hospitalization. Childhood vaccination programs have dramatically reduced measles cases, but outbreaks still occur—often linked to unvaccinated populations or international travel. If you’re wondering, do adults need a measles booster?, the short answer is: it depends on your vaccination history, risk factors, and future plans.

Below, we’ll walk through current expert recommendations, help you determine whether a booster is appropriate for you, and guide you on next steps.


Why Consider a Measles Booster?

  • Waning Immunity: Although two doses of the MMR (measles, mumps, rubella) vaccine in childhood are highly effective (around 97% protection), immunity can decrease over many years.
  • Outbreak Control: In areas experiencing measles outbreaks, additional doses can help halt transmission.
  • High-Risk Situations: Certain professions and life events increase exposure risk.

Who Is Considered Protected Against Measles?

According to U.S. expert panels (including the Advisory Committee on Immunization Practices, or ACIP) and global bodies:

  • Adults born before 1957 are generally presumed immune, since they likely had natural infection.
  • Adults born in 1957 or later need proof of immunity. Proof can be:
    • Documentation of two doses of MMR vaccine (first dose at least 28 days before the second).
    • Laboratory evidence of immunity (positive measles antibody titer).
    • Laboratory confirmation of past measles infection.
    • Documentation of measles diagnosis by a qualified clinician.

If you meet any of these criteria, you’re considered protected and typically do not need an additional booster—unless you fall into a high-risk group (see below).


Which Adults Should Get a Measles Booster?

Even if you’ve completed the standard two-dose series, a third MMR dose may be recommended under certain circumstances:

  1. Outbreaks or High-Exposure Events
    • If you live, work, or will be in an area with an active measles outbreak and lack adequate documentation of immunity, a third dose can give extra protection.
  2. International Travel
    • Adults traveling to regions where measles is still common (e.g., parts of Asia, Africa, the Middle East) should ensure they have two verified doses. If you’ve only had one dose or your records are unclear, talk to your doctor about getting an additional MMR before travel.
  3. Healthcare Personnel
    • Hospitals and clinics often require staff to have documented immunity. If you cannot provide proof of two doses or lab confirmation, you should receive the missing dose(s).
  4. College or Post-Secondary Students
    • Many universities require MMR documentation for enrollment. Check with your student health services; if your records show only one dose, you may be asked to get a second or third dose.
  5. Household Contacts of High-Risk Individuals
    • If you live with someone who’s immunocompromised (e.g., undergoing chemotherapy, living with HIV), adding a booster can reduce the chance of bringing measles into the home.
  6. Laboratory Workers
    • Staff handling specimens with measles virus must prove immunity with two documented doses or a blood test.

How Many Measles Doses Do Adults Need?

  • Standard adult schedule (if never vaccinated or incomplete records):
    • Dose 1: At any time.
    • Dose 2: At least 28 days after Dose 1.
  • Third dose: Consider if you fall into one of the high-risk categories above, especially during an outbreak.

Safety and Side Effects

MMR is a live attenuated vaccine. That means it uses a weakened version of the virus to prompt your immune system to build defenses. Common side effects are mild and temporary:

  • Low-grade fever (1–2 days post-vaccine)
  • Mild rash
  • Soreness, redness, or swelling at the injection site

Severe reactions are very rare. Before vaccinating, discuss any history of severe allergic reactions, pregnancy, or weakened immunity with your healthcare provider.


Talking to Your Doctor

Determining whether you need a measles booster involves reviewing your personal health history, vaccination records, and current risk factors. Here’s how you can prepare for that conversation:

  • Collect any vaccine records or school immunization documents you have.
  • Note any planned international travel, school enrollment, or high-exposure job changes.
  • List any immune-suppressing conditions or household members with health vulnerabilities.
  • Consider starting with a free, online symptom check, using the doctor approved Ubie Symptom Checker to clarify any current concerns or symptoms you may have before scheduling an appointment. (Link: https://ubiehealth.com/)

When you meet with your doctor, you can ask:

  • “Do I have evidence of immunity to measles?”
  • “Would an additional MMR dose benefit me based on my travel plans or workplace requirements?”
  • “Are there any precautions I should be aware of before getting another dose?”

Special Situations

  • Pregnancy: Because MMR is a live vaccine, it’s not given during pregnancy. If you’re not immune and become pregnant, avoid exposure, and plan vaccination after delivery.
  • Immunocompromised Adults: If you have a weakened immune system (e.g., due to certain medications, cancer, or advanced HIV), live vaccines might not be safe. Your doctor may recommend a blood test to check for immunity or discuss alternative protective measures.
  • Allergic Reactions: A history of severe allergic reaction to a previous dose or vaccine component is a contraindication. Discuss options with your healthcare provider.

Key Takeaways

  • Most adults born before 1957 are presumed immune and usually don’t need a booster.
  • Adults born 1957 or later without two documented MMR doses or lab evidence of immunity should get vaccinated: two doses at least 28 days apart.
  • High-risk adults (healthcare workers, travelers, students, outbreak-affected areas) may need an additional (third) dose.
  • Safety: MMR is generally safe. Side effects are mild and short-lived.
  • Pregnancy and immune issues: Special guidance applies. Always check with a healthcare professional.

Next Steps

  1. Review your vaccine records and health history.
  2. If you’re unsure about your immunity status or you fall into a high-risk group, talk to your doctor about whether a measles booster is right for you.
  3. To get started, try a free, online symptom check, using the doctor approved Ubie Symptom Checker: https://ubiehealth.com/
  4. If you experience any serious symptoms—high fever, severe rash, breathing difficulty, neurological signs—seek medical care immediately and discuss your history of measles exposure or vaccination.

Prioritizing up-to-date measles protection not only safeguards your health but also helps protect your family and community. Speak to your doctor today to make an informed choice about your measles immunity and any necessary booster doses.

(References)

  • * Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures. Lancet. 1977 Sep 17;2(8038):571-5. PMID: 71396.

  • * Fel'dman EV, Kapustik LA, Belous TI, Bir'iak VN, Kuznetsova NK. [Effectiveness of the selective revaccination of schoolchildren against measles]. Zh Mikrobiol Epidemiol Immunobiol. 1985 Jun;(6):30-4. PMID: 2930972.

  • * Miroshnikova NK. [Use of a micromethod in the leukocyte migration inhibition test for evaluating the status of cellular immunity in measles]. Tr Inst Im Pastera. 1985;62:54-8. PMID: 3843363.

  • * Arbeter AM, Arthur JH, Blakeman GJ, McIntosh K. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin. J Pediatr. 1972 Oct;81(4):737-41. doi: 10.1016/s0022-3476(72)80094-5. PMID: 4116365.

  • * Sokhin AA, Sliusar' LI, Popov VF, Noskov FS, Radomskaia FS. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels]. Zh Mikrobiol Epidemiol Immunobiol. 1983 Sep;(9):79-85. PMID: 6637278.

  • * Roberts RJ, Sandifer QD, Evans MR, Nolan-Farrell MZ, Davis PM. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine. BMJ. 1995 Jun 24;310(6995):1629-32. doi: 10.1136/bmj.310.6995.1629. PMID: 7795447; PMCID: PMC2550008.

  • * Rafuse J. Catch-up immunization programs will eliminate measles threat for most schoolchildren. CMAJ. 1996 May 15;154(10):1567-8. PMID: 8625011; PMCID: PMC1487832.

  • * Abramow-Newerly W, Litwińska B, Litwińska J, Sadowski W, Kańtoch M. Primary and secondary immune response to measles vaccine strain. Acta Microbiol Pol. 1980;29(3):227-32. PMID: 19852108.

  • * Shirts BH, Welch RJ, Couturier MR. Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination. Clin Vaccine Immunol. 2013 Mar;20(3):443-5. doi: 10.1128/CVI.00503-12. Epub 2013 Jan 23. PMID: 23345583; PMCID: PMC3592343.

  • * McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. PMID: 23760231.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.